Abstract
This chapter reviews the expression and regulation of opioid receptors in sensory neurons and the interactions of these receptors with endogenous and exogenous opioid ligands. Inflammation of peripheral tissues leads to increased synthesis and axonal transport of opioid receptors in dorsal root ganglion neurons. This results in opioid receptor upregulation and enhanced G protein coupling at peripheral sensory nerve terminals. These events are dependent on neuronal electrical activity, and on production of proinflammatory cytokines and nerve growth factor within the inflamed tissue. Together with the disruption of the perineurial barrier, these factors lead to an enhanced analgesic efficacy of peripherally active opioids. The major local source of endogenous opioid ligands (e.g. β-endorphin) is leukocytes. These cells contain and upregulate signal-sequence-encoding messenger RNA of the β-endorphin precursor proopiomelanocortin and the entire enzymatic machinery necessary for its processing into the functionally active peptide. Opioid-containing immune cells extravasate using adhesion molecules and chemokines to accumulate in inflamed tissues. Upon stressful stimuli or in response to releasing agents such as corticotropin-releasing factor, cytokines, chemokines, and catecholamines, leukocytes secrete opioids. Depending on the cell type, this release is contingent on extracellular Ca2+ or on inositol triphosphate receptor triggered release of Ca2+ from endoplasmic reticulum. Once secreted, opioid peptides activate peripheral opioid receptors and produce analgesia by inhibiting the excitability of sensory nerves and/or the release of proinflammatory neuropeptides. These effects occur without central untoward side effects such as depression of breathing, clouding of consciousness, or addiction. Future aims include the development of peripherally restricted opioid agonists, selective targeting of opioid-containing leukocytes to sites of painful injury, and the augmentation of peripheral opioid peptide and receptor synthesis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akins PT, McCleskey EW (1993) Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 56:759–769
American Society of Anesthesiologists Task Force on Acute Pain Management (2004) Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 100:1573–1581
Antonijevic I, Mousa SA, Schäfer M, Stein C (1995) Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 15:165–172
Baamonde A, Lastra A, Juarez L, Garcia V, Hidalgo A, Menendez L (2005) Effects of the local administration of selective mu-, delta- and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol 372:213–219
Baamonde A, Lastra A, Juarez L, Garcia-Suarez O, Meana A, Hidalgo A, Menendez L (2006) Endogenous beta-endorphin induces thermal analgesia at the initial stages of a murine osteosarcoma. Peptides 27:2778–2785
Ballet S, Conrath M, Fischer J, Kaneko T, Hamon M, Cesselin F (2003) Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats. Neuropeptides 37:211–219
Bartho L, Stein C, Herz A (1990) Involvement of capsaicin-sensitive neurones in hyperalgesia and enhanced opioid antinociception in inflammation. Naunyn Schmiedebergs Arch Pharmacol 342:666–670
Beland B, Fitzgerald M (2001) Mu- and delta-opioid receptors are downregulated in the largest diameter primary sensory neurons during postnatal development in rats. Pain 90: 143–150
Berg KA, Zardeneta G, Hargreaves KM, Clarke WP, Milam SB (2007a) Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience 144:889–897
Berg KA, Patwardhan AM, Sanchez TA, Silva YM, Hargreaves KM, Clarke WP (2007b) Rapid modulation of mu-opioid receptor signaling in primary sensory neurons. J Pharmacol Exp Ther 321:839–847
Bergström J, Ahmed M, Li J, Ahmad T, Kreicbergs A, Spetea M (2006) Opioid peptides and receptors in joint tissues: study in the rat. J Orthop Res 24:1193–1199
Beutler AS, Banck MS, Walsh CE, Milligan ED (2005) Intrathecal gene transfer by adeno-associated virus for pain. Curr Opin Mol Ther 7:431–439
Bileviciute-Ljungar I, Spetea M, Guo Y, Schutz J, Windisch P, Schmidhammer H (2006) Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5α-epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation. J Pharmacol Exp Ther 317:220–227
Binder W, Mousa SA, Sitte N, Kaiser M, Stein C, Schäfer M (2004) Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. Eur J Neurosci 20:92–100
Brack A, Rittner HL, Machelska H, Beschmann K, Sitte N, Schäfer M, Stein C (2004a) Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology 100:149–157
Brack A, Rittner HL, Machelska H, Leder K, Mousa SA, Schafer M, Stein C (2004b) Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 112:229–238
Brack A, Labuz D, Schiltz A, Rittner HL, Machelska H, Schafer M, Reszka R, Stein C (2004c) Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception. Anesthesiology 101:204–211
Brower V (2000) New paths to pain relief. Nat Biotechnol 18:387–391
Buzas B, Cox BM (1997) Quantitative analysis of mu- and delta-opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience 76:479–489
Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schäfer M, Loeffler JP, Stein C (1997) Immune cell-derived β-endorphin: production, release and control of inflammatory pain in rats. J Clin Invest 100:142–148
Cabot PJ, Carter L, Schäfer M, Stein C (2001) Methionine-enkephalin- and dynorphin A-release from immune cells and control of inflammatory pain. Pain 93:207–212
Calza L, Pozza M, Zanni M, Manzini CU, Manzini E, Hokfelt T (1998) Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience 82:575–589
Carlton SM, Coggeshall RE (1997) Immunohistochemical localization of enkephalin in peripheral sensory axons in the rat. Neurosci Lett 221:121–124
Chadzinska M, Starowicz K, Scislowska-Czarnecka A, Bilecki W, Pierzchala-Koziec K, Przewlocki R, Przewlocka B, Plytycz B (2005) Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice. Immunol Lett 101:185–192
Chakass D, Philippe D, Erdual E, Dharancy S, Malapel M, Dubuquoy C, Thuru X, Gay J, Gaveriaux-Ruff C, Dubus P, Mathurin P, Kieffer BL, Desreumaux P, Chamaillard M (2007) Mu-opioid receptor activation prevents acute hepatic inflammation and cell death. Gut 56:974–981
Chen JJ, Dymshitz J, Vasko MR (1997) Regulation of opioid receptors in rat sensory neurons in culture. Mol Pharmacol 51:666–673
Chen CL, Broom DC, Liu Y, de Nooij JC, Li Z, Cen C, Samad OA, Jessell TM, Woolf CJ, Ma Q (2006) Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain. Neuron 49:365–377
Coggeshall RE, Zhou S, Carlton SM (1997) Opiate receptors on peripheral sensory axons. Brain Res 764:126–132
Craft RM, Henley SR, Haaseth RC, Hruby VJ, Porreca F (1995) Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther 275:1535–1542
Crowe R, Parkhouse N, McGrouther D, Burnstock G (1994) Neuropeptide-containing nerves in painful hypertrophic human scar tissue. Br J Dermatol 130:444–452
Cunha FQ, Ferreira SH (2003) Peripheral hyperalgesic cytokines. Adv Exp Med Biol 521:22–39
Czlonkowski A, Stein C, Herz A (1993) Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur J Pharmacol 242:229–235
Dahan A, van Dorp E, Smith T, Yassen A (2008) Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur J Pain 12:403–411
DeHaven-Hudkins DL, Dolle RE (2004) Peripherally restricted opioid agonists as novel analgesic agents. Curr Pharm Des 10:743–757
Eisenach JC, Carpenter R, Curry R (2003) Analgesia from a peripherally active κ-opioid receptor agonist in patients with chronic pancreatitis. Pain 101:89–95
Eisinger DA, Ammer H, Schulz R (2002) Chronic morphine treatment inhibits opioid receptor desensitization and internalization. J Neurosci 22:10192–10200
Endres-Becker J, Heppenstall PA, Mousa SA, Labuz D, Oksche A, Schäfer M, Stein C, Zöllner C (2007) Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol 71:12–18
Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH (1992) Cloning of a delta-opioid receptor by functional expression. Science 258:1952–1955
Fichna J, Janecka A, Costentin J, Do Rego JC (2007) The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 59:88–123
Fürst S, Riba P, Friedmann T, Timar J, Al-Khrasani M, Obara I, Makuch W, Spetea M, Schutz J, Przewlocki R, Przewlocka B, Schmidhammer H (2005) Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat. J Pharmacol Exp Ther 312:609–618
Gendron L, Lucido AL, Mennicken F, O'Donnell D, Vincent JP, Stroh T, Beaudet A (2006) Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J Neurosci 26:953–962
Gibbins IL, Furness JB, Costa M (1987) Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea pig. Cell Tissue Res 248:417–437
Gold MS, Levine JD (1996) DAMGO inhibits prostaglandin E2-induced potentiation of a TTX-resistant Na+ current in rat sensory neurons in vitro. Neurosci Lett 212:83–86
Hanna MH, Elliott KM, Fung M (2005) Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery. Anesthesiology 102:815–821
Hanninen A, Salmi M, Simell O, Andrew D, Jalkanen S (1996) Recirculation and homing of lymphocyte subsets: dual homing specificity of beta 7-integrin(high)-lymphocytes in nonobese diabetic mice. Blood 88:934–944
Hargreaves KM, Dubner R, Costello AH (1989) Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur J Pharmacol 170:275–279
Hassan AHS, Ableitner A, Stein C, Herz A (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55:185–195
Herlitze S, Garcia DE, Mackie K, Hille B, Scheuer T, Catterall WA (1996) Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature 380:258–262
Hermanussen S, Do M, Cabot PJ (2004) Reduction of beta-endorphin-containing immune cells in inflamed paw tissue corresponds with a reduction in immune-derived antinociception: reversible by donor activated lymphocytes. Anesth Analg 98:723–729
Heurich M, Mousa SA, Lenzner M, Morciniec P, Kopf A, Welte M, Stein C (2007) Influence of pain treatment by epidural fentanyl and bupivacaine on homing of opioid-containing leukocytes to surgical wounds. Brain Behav Immun 21:544–552
Hook S, Camberis M, Prout M, Konig M, Zimmer A, Van Heeke G, Le Gros G (1999) Preproenkephalin is a Th2 cytokine but is not required for Th2 differentiation in vitro. Immunol Cell Biol 77:385–390
Hua S, Hermanussen S, Tang L, Monteith GR, Cabot PJ (2006) The neural cell adhesion molecule antibody blocks cold water swim stress-induced analgesia and cell adhesion between lymphocytes and cultured dorsal root ganglion neurons. Anesth Analg 103:1558–1564
Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP Jr (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 102:3093–3098
Ingram SL, Williams JT (1994) Opioid inhibition of Ih via adenylyl cyclase. Neuron 13:179–186
Jaber L, Swaim WD, Dionne RA (2003) Immunohistochemical localization of mu-opioid receptors in human dental pulp. J Endod 29:108–110
Jeanjean AP, Moussaoui SM, Maloteaux J-M, Laduron PM (1995) Interleukin-1β induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 68:151–157
Ji R-R, Zhang Q, Law P-Y, Low HH, Elde R, Hökfelt T (1995) Expression of μ-, δ-, and κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15:8156–8166
Kabli N, Cahill CM (2007) Anti-allodynic effects of peripheral delta-opioid receptors in neuropathic pain. Pain 127:84–93
Kalso E, Smith L, McQuay HJ, Moore RA (2002) No pain, no gain: clinical excellence and scientific rigour – lessons learned from IA morphine. Pain 98:269–275
Kavelaars A, Ballieux RE, Heijnen CJ (1990) In vitro beta-adrenergic stimulation of lymphocytes induces the release of immunoreactive beta-endorphin. Endocrinology 126:3028–3032
Khodorova A, Navarro B, Jouaville LS, Murphy JE, Rice FL, Mazurkiewicz JE, Long-Woodward D, Stoffel M, Strichartz GR, Yukhananov R, Davar G (2003) Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat Med 9:1055–1061
Kieffer BL, Gaveriaux-Ruff C (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66:285–306
Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89:12048–12052
Koch T, Widera A, Bartzsch K, Schulz S, Brandenburg LO, Wundrack N, Beyer A, Grecksch G, Hollt V (2005) Receptor endocytosis counteracts the development of opioid tolerance. Mol Pharmacol 67:280–287
Kondo I, Marvizon JC, Song B, Salgado F, Codeluppi S, Hua XY, Yaksh TL (2005) Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J Neurosci 25:3651–3660
Kopf A, Schmidt S, Stein C (2006) Topical administration of analgesics. In: Bruera E, Higginson IJ, Ripamonti C, von Gunten CF (eds) Textbook of palliative medicine. Hodder Arnold, London, pp 450–457
Kraus J, Borner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W, Höllt V (2001) Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 276:43901–43908
Kyrkanides S, Fiorentino PM, Miller JN, Gan Y, Lai YC, Shaftel SS, Puzas JE, Piancino MG, O'Banion MK, Tallents RH (2007) Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1beta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint. Arthritis Rheum 56:2038–2048
Labuz D, Berger S, Mousa SA, Zöllner C, Rittner HL, Shaqura MA, Segovia-Silvestre T, Przewlocka B, Stein C, Machelska H (2006) Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci 26:4350–4358
Labuz D, Mousa SA, Schafer M, Stein C, Machelska H (2007) Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res 1160:30–38
LaMendola J, Martin SK, Steiner DF (1997) Expression of PC3, carboxypeptidase E and enkephalin in human monocyte-derived macrophages as a tool for genetic studies. FEBS Lett 404:19–22
Law PY, Wong YH, Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389–430
Ledford H (2007) Fever pitch. Nature 450:600–601
Li JL, Kaneko T, Mizuno N (1996) Effects of peripheral nerve ligation on expression of mu-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat. Neurosci Lett 214:91–94
Li JL, Ding YQ, Li YQ, Li JS, Nomura S, Kaneko T, Mizuno N (1998) Immunocytochemical localization of mu-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat. Brain Res 794:347–352
Likar R, Schäfer M, Paulak F, Sittl R, Pipam W, Schalk H, Geissler D, Bernatzky G (1997) Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg 84:1313–1317
Likar R, Mousa SA, Philippitsch G, Steinkellner H, Koppert W, Stein C, Schäfer M (2004) Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia. Br J Anaesth 93:375–380
Likar R, Mousa SA, Steinkellner H, Koppert W, Philippitsch G, Stein C, Schafer M (2007) Involvement of intra-articular corticotropin-releasing hormone in postoperative pain modulation. Clin J Pain 23:136–142
Lyons PD, Blalock JE (1997) Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunol 78:47–56
Machelska H (2007) Targeting of opioid-producing leukocytes for pain control. Neuropeptides 41:355–363
Machelska H, Cabot PJ, Mousa SA, Zhang Q, Stein C (1998) Pain control in inflammation governed by selectins. Nat Med 4:1425–1428
Machelska H, Pflüger M, Weber W, Piranvisseh-Volk M, Daubert JD, Dehaven R, Stein C (1999) Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J Pharmacol Exp Ther 290:354–361
Machelska H, Mousa SA, Brack A, Schopohl JK, Rittner HL, Schäfer M, Stein C (2002) Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J Neurosci 22:5588–5596
Machelska H, Schopohl JK, Mousa SA, Labuz D, Schafer M, Stein C (2003) Different mechanisms of intrinsic pain inhibition in early and late inflammation. J Neuroimmunol 141:30–39
Machelska H, Brack A, Mousa SA, Schopohl JK, Rittner HL, Schafer M, Stein C (2004) Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain. Br J Pharmacol 142:772–780
Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ (1994) Mu, delta, and kappa-opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350:412–438
Martin-Schild S, Gerall AA, Kastin AJ, Zadina JE (1998) Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides 19:1783–1789
Mata M, Glorioso JC, Fink DJ (2002) Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiol Behav 77:483–488
Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H (1993) Cloning and pharmacological characterization of a rat kappa-opioid receptor. Proc Natl Acad Sci USA 90:9954–9958
Minami M, Maekawa K, Yabuuchi K, Satoh M (1995) Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Brain Res Mol Brain Res 30:203–210
Mousa SA, Schäfer M, Mitchell WM, Hassan AHS, Stein C (1996) Local upregulation of corticotropin- releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol 311:221–231
Mousa SA, Machelska H, Schäfer M, Stein C (2000) Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain. J Neuroimmunol 108:160–170
Mousa SA, Zhang Q, Sitte N, Ji R, Stein C (2001) beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115:71–78
Mousa SA, Machelska H, Schäfer M, Stein C (2002) Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126:5–15
Mousa SA, Bopaiah CP, Stein C, Schafer M (2003) Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 106:297–307
Mousa SA, Shakibaei M, Sitte N, Schäfer M, Stein C (2004) Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145:1331–1341
Mousa SA, Straub RH, Schafer M, Stein C (2007a) Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 66:871–879
Mousa SA, Cheppudira BP, Shaqura M, Fischer O, Hofmann J, Hellweg R, Schafer M (2007b) Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 130:502–513
Obara I, Makuch W, Spetea M, Schutz J, Schmidhammer H, Przewlocki R, Przewlocka B (2007) Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur J Pharmacol 558:60–67
Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21:5027–5035
Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, Hargreaves KM (2005) Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 25:8825–8832
Philippe D, Dubuquoy L, Groux H, Brun V, Chuoi-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, Desreumaux P (2003) Anti-inflammatory properties of the mu-opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 111:1329–1338
Picard PR, Tramer MR, McQuay HJ, Moore RA (1997) Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 72:309–318
Pierce TL, Grahek MD, Wessendorf MW (1998) Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey. Neuroreport 9:385–389
Pohl M, Collin E, Bourgoin S, Conrath M, Benoliel JJ, Nevo I, Hamon M, Giraud P, Cesselin F (1994) Expression of preproenkephalin A gene and presence of Met-enkephalin in dorsal root ganglia of the adult rat. J Neurochem 63:1226–1234
Pohl M, Meunier A, Hamon M, Braz J (2003) Gene therapy of chronic pain. Curr Gene Ther 3:223–238
Pol O, Murtra P, Caracuel L, Valverde O, Puig MM, Maldonado R (2006) Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain. Neuropharmacology 50:123–132
Polydefkis M, Griffin JW, McArthur J (2003) New insights into diabetic polyneuropathy. JAMA 290:1371–1376
Przewlocki R, Gramsch C, Pasi A, Herz A (1983) Characterization and localization of immunoreactive dynorphin, alpha-neoendorphin, met-enkephalin and substance P in human spinal cord. Brain Res 280:95–103
Przewlocki R, Hassan AHS, Lason W, Epplen C, Herz A, Stein C (1992) Gene expression and localization of opioid peptides in immune cells of inflamed tissue. Functional role in antinociception. Neuroscience 48:491–500
Pühler W, Zollner C, Brack A, Shaqura MA, Krause H, Schafer M, Stein C (2004) Rapid upregulation of mu-opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129:473–479
Pühler W, Rittner HL, Mousa SA, Brack A, Krause H, Stein C, Schafer M (2006) Interleukin-1 beta contributes to the upregulation of kappa-opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation. Neuroscience 141:989–998
Quartu M, Del Fiacco M (1994) Enkephalins occur and colocalize with substance P in human trigeminal ganglion neurones. Neuroreport 5:465–468
Rasenick MM, Childers SR (1989) Modification of Gs-stimulated adenylate cyclase in brain membranes by low pH pretreatment: correlation with altered guanine nucleotide exchange. J Neurochem 53:219–225
Rashid MH, Inoue M, Toda K, Ueda H (2004) Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther 309:380–387
Rau KK, Caudle RM, Cooper BY, Johnson RD (2005) Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia. J Chem Neuroanat 29:255–264
Reichert JA, Daughters RS, Rivard R, Simone DA (2001) Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 89:221–227
Rittner HL, Brack A, Machelska H, Mousa SA, Bauer M, Schäfer M, Stein C (2001) Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95:500–508
Rittner HL, Machelska H, Stein C (2005) Leukocytes in the regulation of pain and analgesia. J Leukoc Biol 78:1215–1222
Rittner HL, Mousa SA, Labuz D, Beschmann K, Schafer M, Stein C, Brack A (2006a) Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain. J Leukoc Biol 79:1022–1032
Rittner HL, Labuz D, Schaefer M, Mousa SA, Schulz S, Schafer M, Stein C, Brack A (2006b) Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells. FASEB J 20:2627–2629
Rittner HL, Lux C, Labuz D, Mousa SA, Schafer M, Stein C, Brack A (2007a) Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception. Anesthesiology 107:1009–1017
Rittner HL, Labuz D, Richter JF, Brack A, Schafer M, Stein C, Mousa SA (2007b) CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo. Brain Behav Immun 21:1021–1032
Rittner HL, Brack A, Stein C (2008) The other side of the medal: How chemokines promote analgesia. Neurosci Lett 437:203–208
Riviere PJ (2004) Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol 141:1331–1334
Sawynok J (2003) Topical and peripherally acting analgesics. Pharmacol Rev 55:1–20
Schäfer M, Carter L, Stein C (1994) Interleukin-1β and corticotropin-releasing-factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 91:4219–4223
Schäfer M, Mousa SA, Zhang Q, Carter L, Stein C (1996) Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA 93:6096–6100
Schmitt TK, Mousa SA, Brack A, Schmidt DK, Rittner HL, Welte M, Schäfer M, Stein C (2003) Modulation of peripheral endogenous opioid analgesia by central afferent blockade. Anesthesiology 98:195–202
Selley DE, Breivogel CS, Childers SR (1993) Modification of G protein-coupled functions by low pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol Pharmacol 44:731–741
Shannon HE, Lutz EA (2002) Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology 42:253–261
Shaqura MA, Zöllner C, Mousa SA, Stein C, Schäfer M (2004) Characterization of mu-opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther 308:712–718
Silbert SC, Beacham DW, McCleskey EW (2003) Quantitative single-cell differences in mu-opioid receptor mRNA distinguish myelinated and unmyelinated nociceptors. J Neurosci 23:34–42
Sitte N, Busch M, Mousa SA, Labuz D, Rittner H, Gore C, Krause H, Stein C, Schafer M (2007) Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo. J Neuroimmunol 183:133–145
Smith EM (2003) Opioid peptides in immune cells. Adv Exp Med Biol 521:51–68
Ständer S, Gunzer M, Metze D, Luger T, Steinhoff M (2002) Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin. Regul Pept 110:75–83
Stein C (1993) Peripheral mechanisms of opioid analgesia. Anesth Analg 76:182–191
Stein C (1995) The control of pain in peripheral tissue by opioids. N Engl J Med 332:1685–1690
Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 248:1269–1275
Stein C, Gramsch C, Herz A (1990a) Intrinsic mechanisms of antinociception in inflammation. Local opioid receptors and β-endorphin. J Neurosci 10:1292–1298
Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, Herz A (1990b) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 87:5935–5939
Stein C, Comisel K, Haimerl E, Yassouridis A, Lehrberger K, Herz A, Peter K (1991) Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N Engl J Med 325:1123–1126
Stein C, Hassan AHS, Lehrberger K, Giefing J, Yassouridis A (1993) Local analgesic effect of endogenous opioid peptides. Lancet 342:321–324
Stein C, Pflüger M, Yassouridis A, Hoelzl J, Lehrberger K, Welte C, Hassan AHS (1996) No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 98:793–799
Stein A, Yassouridis A, Szopko C, Helmke K, Stein C (1999) Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 83:525–532
Stein C, Machelska H, Schäfer M (2001) Peripheral analgesic and anti-inflammatory effects of opioids. Z Rheumatol 60:416–424
Stein C, Schäfer M, Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9:1003–1008
Sternini C, Spann M, Anton B, Keith DE Jr, Bunnett NW, von Zastrow M, Evans C, Brecha NC (1996) Agonist-selective endocytosis of mu-opioid receptor by neurons in vivo. Proc Natl Acad Sci USA 93:9241–9246
Straub RH, Wolff C, Fassold A, Hofbauer R, Chover-Gonzalez A, Richards LJ, Jessop DS (2008) Anti-inflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. Arthritis Rheum 58:456–466
Sweetnam PM, Wrathall JR, Neale JH (1986) Localization of dynorphin gene product-immunoreactivity in neurons from spinal cord and dorsal root ganglia. Neuroscience 18:947–955
Szabo I, Chen XH, Xin L, Adler MW, Howard OM, Oppenheim JJ, Rogers TJ (2002) Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci USA 99:10276–10281
Tegeder I, Geisslinger G (2004) Opioids as modulators of cell death and survival--unraveling mechanisms and revealing new indications. Pharmacol Rev 56:351–369
Tegeder I, Meier S, Burian M, Schmidt H, Geisslinger G, Lotsch J (2003) Peripheral opioid analgesia in experimental human pain models. Brain 126:1092–1102
Terman GW, Shavit Y, Lewis JW, Cannon JT, Liebeskind JC (1984) Intrinsic mechanisms of pain inhibition: activation by stress. Science 226:1270–1277
Truong W, Cheng C, Xu QG, Li XQ, Zochodne DW (2003) Mu-opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol 53:366–375
Verma-Gandhu M, Bercik P, Motomura Y, Verdu EF, Khan WI, Blennerhassett PA, Wang L, El-Sharkawy RT, Collins SM (2006) CD4+ T-cell modulation of visceral nociception in mice. Gastroenterology 130:1721–1728
Vetter I, Kapitzke D, Hermanussen S, Monteith GR, Cabot PJ (2006) The effects of pH on beta-endorphin and morphine inhibition of calcium transients in dorsal root ganglion neurons. J Pain 7:488–499
Vindrola O, Mayer AMS, Citera G, Spitzer JA, Espinoza LR (1994) Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages. Neuropeptides 27:235–244
von Andrian UH, Mackay CR (2000) T-cell function and migration. Two sides of the same coin. N Engl J Med 343:1020–1034
Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P (2005) Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience 132:1093–1102
Wang H, Wessendorf MW (2001) Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J Comp Neurol 429:590–600
Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE, Uhl GR (1993) Mu-opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci USA 90:10230–10234
Weihe E, Hartschuh W, Weber E (1985) Prodynorphin opioid peptides in small somatosensory primary afferents of guinea pig. Neurosci Lett 58:347–352
Wenk HN, Honda CN (1999) Immunohistochemical localization of delta-opioid receptors in peripheral tissues. J Comp Neurol 408:567–579
Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, Murray SR, Von Zastrow M (2002) Modulation of postendocytic sorting of G protein-coupled receptors. Science 297:615–620
Willer JC, Dehen H, Cambier J (1981) Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science 212:689–691
Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288: 1765–1769
Yaksh TL (1988) Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res 458:319–324
Zhang Q, Schäfer M, Elde R, Stein C (1998a) Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia. Neuroscience 85:281–291
Zhang X, Bao L, Arvidsson U, Elde R, Hökfelt T (1998b) Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 82:1225–1242
Zhang X, Bao L, Shi TJ, Ju G, Elde R, Hökfelt T (1998c) Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 82:223–240
Zhang X, Bao L, Guan JS (2006) Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 27:324–329
Zhou L, Zhang Q, Stein C, Schðfer M (1998) Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 286(2):1000–1006
Zhu Y, Hsu MS, Pintar JE (1998) Developmental expression of the mu-, kappa-, and delta-opioid receptor mRNAs in mouse. J Neurosci 18:2538–2549
Zöllner C, Stein C (2007) Opioids. Handb Exp Pharmacol 177:31–63
Zöllner C, Shaqura MA, Bopaiah CP, Mousa SA, Stein C, Schäfer M (2003) Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64:202–210
Zöllner C, Mousa SA, Fischer O, Rittner HL, Shaqura M, Brack A, Shakibaei M, Binder W, Urban F, Stein C, Schäfer M (2008) Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest 118:1065–1073
Acknowledgements
This work was supported by grants from the Deutsche Forschungsgemein-schaft (KFO 100) and the International Anesthesia Research Society.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stein, C., Zöllner, C. (2009). Opioids and Sensory Nerves. In: Canning, B., Spina, D. (eds) Sensory Nerves. Handbook of Experimental Pharmacology, vol 194. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79090-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-540-79090-7_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79089-1
Online ISBN: 978-3-540-79090-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)